Yueyin Pan

3 articles listing Yueyin Pan in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306) Nature Communications
2. Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial Nature Communications
3. Comprehensive profiling of the catalytic conformations of human Guanylate kinase Nature Communications